SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,702,000 | +8.0% | 2,308,079 | +94.6% | 1.54% | +12.8% |
| Q4 2018 | $13,613,000 | +134.0% | 1,185,831 | +245.5% | 1.36% | +159.9% |
| Q3 2018 | $5,818,000 | -72.9% | 343,231 | -77.3% | 0.52% | -74.3% |
| Q2 2018 | $21,437,000 | +542.6% | 1,509,671 | +578.8% | 2.04% | +358.7% |
| Q3 2017 | $3,336,000 | -85.2% | 222,388 | -91.3% | 0.44% | -88.9% |
| Q2 2017 | $22,599,000 | – | 2,568,119 | – | 4.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |